Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure (Q28391110)

positron emission tomography

inferred from title

1 reference

Corrigendum: Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure

inferred from title

corrigendum / erratum

0 references

Corrigendum: Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure.

0 references

Stephanus T Malherbe

1

0 references

Katharina Ronacher

Katharina Ronacher

3

0 references

André G. Loxton

Andre G Loxton

4

0 references

Gerhard Walzl

Gerhard Walzl

18

0 references

Gerard Tromp

Gerard Tromp

14

0 references

Gian D Van Der Spuy

Gian van der Spuy

21

0 references

Laura Via

Laura E Via

10

0 references

Magdalena Kriel

6

Magdalena Kriel

0 references

Stanley E Kim

22

Kim Stanley

0 references

Gregory M Dolganov

5

Gregory Dolganov

0 references

Gary K Schoolnik

13

Gary Schoolnik

0 references

Caroline G G Beltran

26

Caroline G G Beltran

0 references

Elizna Maasdorp

27

Elizna Maasdorp

0 references

Annare Ellmann

28

Annare Ellmann

0 references

author name string

Shubhada Shenai

2

0 references

Tran Van

7

0 references

Ray Y Chen

8

0 references

James Warwick

9

0 references

Taeksun Song

11

0 references

Myungsun Lee

12

0 references

David Alland

15

0 references

Clifton E Barry

16

0 references

Jill Winter

17

0 references

Lance Lucas

20

0 references

Lani Theart

23

0 references

Bronwyn Smith

24

0 references

Nelita Burger

25

0 references

Hongjo Choi

29

0 references

Joonsung Joh

30

0 references

Lori E Dodd

31

0 references

Brian Allwood

32

0 references

Coenie Kogelenberg

33

0 references

Morné Vorster

34

0 references

Stephanie Griffith-Richards

Pulmonary impairment after tuberculosis and its contribution to TB burden

35

0 references

language of work or name

English

0 references

publication date

October 2016

0 references

published in

Nature Medicine

0 references

volume

22

0 references

issue

10

0 references

page(s)

1094-1100

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

The Mycobacterium tuberculosis regulatory network and hypoxia

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

18F-FDG PET/CT in the Initial Assessment and for Follow-up in Patients With Tuberculosis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Dormant non-culturable Mycobacterium tuberculosis retains stable low-abundant mRNA.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Chronic symptoms and pulmonary dysfunction in post-tuberculosis Brazilian patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

High-dose rifapentine with moxifloxacin for pulmonary tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

A four-month gatifloxacin-containing regimen for treating tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Early Changes by (18)Fluorodeoxyglucose positron emission tomography coregistered with computed tomography predict outcome after Mycobacterium tuberculosis infection in cynomolgus macaques

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Radiologic Responses in Cynomolgus Macaques for Assessing Tuberculosis Chemotherapy Regimens

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Relapse more common than reinfection in recurrent tuberculosis 1-2 years post treatment in urban Uganda

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Global analysis of mRNA stability in Mycobacterium tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Retreatment tuberculosis in a South African community: the role of re-infection, HIV and antiretroviral treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [¹⁸F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Risk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in Morocco

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

A simple, valid, numerical score for grading chest x-ray severity in adult smear-positive pulmonary tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South Africa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Long term efficacy of DOTS regimens for tuberculosis: systematic review.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

How good are systemic symptoms and blood inflammatory markers at detecting individuals with tuberculosis?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

TBscore: Signs and symptoms from tuberculosis patients in a low-resource setting have predictive value and may be used to assess clinical course.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Detection of mRNA transcripts and active transcription in persistent Mycobacterium tuberculosis induced by exposure to rifampin or pyrazinamide

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Basic Mechanisms of Chemotherapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

An unbiased genome-wide Mycobacterium tuberculosis gene expression approach to discover antigens targeted by human T cells expressed during pulmonary infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Expert opinions on positron emission tomography and computed tomography imaging in lymphoma

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Shortening treatment for tuberculosis--to basics

2 June 2018

1 reference

Clinical significance of residual lesions in chest computed tomography after anti-tuberculosis treatment.

21 January 2018

1 reference

Using the St. George respiratory questionnaire to ascertain health quality in persons with treated pulmonary tuberculosis.

21 January 2018

1 reference

Effects of image characteristics on performance of tumor delineation methods: a test-retest assessment

21 January 2018

1 reference

Standard uptake value and metabolic tumor volume of ¹⁸F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer.

21 January 2018

1 reference

Usefulness of 18F-fluorodeoxyglucose positron emission tomography for diagnosing disease activity and monitoring therapeutic response in patients with pulmonary mycobacteriosis

21 January 2018

1 reference

Use of 18F-FDG PET to predict response to first-line tuberculostatics in HIV-associated tuberculosis.

21 January 2018

1 reference

Degradation of 16S rRNA and attributes of viability of viable but nonculturable probiotic bacteria.

21 January 2018

1 reference

The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study.

21 January 2018

1 reference

Patients with active tuberculosis often have different strains in the same sputum specimen

21 January 2018

1 reference

Reproducibility of 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET tumor volume measurements

21 January 2018

1 reference

Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma.

21 January 2018

1 reference

Post-bronchoscopy sputum: improving the diagnostic yield in smear negative pulmonary TB.

21 January 2018

1 reference

Tuberculosis case definition: time for critical re-assessment?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5053881

Pulmonary impairment after tuberculosis

27 November 2018

1 reference

12 December 2020

(18)F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response

1 reference

12 December 2020

Bronchoscopy for the diagnosis of pulmonary tuberculosis in patients with negative sputum smear microscopy results

1 reference

12 December 2020

Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients

1 reference

12 December 2020

Potential role of F18 FDG PET-CT as an imaging biomarker for the noninvasive evaluation in uncomplicated skeletal tuberculosis: a prospective clinical observational study

1 reference

12 December 2020

Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities

1 reference

12 December 2020

Functional profile of patients with tuberculosis sequelae in a university hospital

1 reference

12 December 2020

Comparison of sputum induction with fiberoptic bronchoscopy in the diagnosis of tuberculosis: experience at an acquired immune deficiency syndrome reference center in Rio de Janeiro, Brazil

1 reference

12 December 2020

Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk

1 reference

12 December 2020

Radiographic resolution of community-acquired pneumonia

1 reference

12 December 2020

Post-tuberculous chronic obstructive pulmonary disease

1 reference

12 December 2020